[Role of polyol pathway in pathogenesis of diabetic microangiopathy].
Nakamura
Jiro
J
Division of Metabolic Diseases, Department of Internal Medicine, Nagoya University Graduate School of Medicine.
D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors / Q000235:genetics / Q000502:physiology*; D000818:Animals; D003925:Diabetic Angiopathies / Q000209:etiology* / Q000517:prevention & control; D005632:Fructose / Q000378:metabolism; D005947:Glucose / Q000378:metabolism; D017127:Glycation End Products, Advanced / Q000378:metabolism; D006801:Humans; D007064:L-Iditol 2-Dehydrogenase / Q000502:physiology; D018384:Oxidative Stress; D011108:Polymers / Q000378:metabolism*; D011110:Polymorphism, Genetic; D011493:Protein Kinase C / Q000378:metabolism; D011719:Pyrazines / Q000494:pharmacology / Q000627:therapeutic use; D013012:Sorbitol / Q000378:metabolism; D013141:Spiro Compounds / Q000494:pharmacology / Q000627:therapeutic use
D017127:Glycation End Products, Advanced; D011108:Polymers; D011719:Pyrazines; D013141:Spiro Compounds; C024617:polyol; D005632:Fructose; D013012:Sorbitol; D007064:L-Iditol 2-Dehydrogenase; D000449:Aldehyde Reductase; D011493:Protein Kinase C; D005947:Glucose; C115070:ranirestat